CSF3 and neutropenia: Recombinant granulocyte-colony stimulating factor (G-CSF) preparations have emerged as effective supportive therapies for chemotherapy-induced neutropenia, of which the clinical efficacy has been confirmed by numerous clinical trials, and generally recommended by guidelines [4–9].